Alembic Ltd's Q4FY25 Quarter Results
- 14 May 2025
Result Summary
- Alembic Ltd reported a 18.0% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 30.4%.
- Its expenses for the quarter were down by 23.0% QoQ and up 5.3% YoY.
- The net profit increased 10.3% QoQ and increased 49.5% YoY.
- The earnings per share (EPS) of Alembic Ltd stood at 2.8 during Q4FY25.
Financial Statments for Q4FY25
| (₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 51.08 | 62.29 | 39.16 | -18.0% | 30.4% |
Total Expenses | 26.86 | 34.90 | 25.51 | -23.0% | 5.3% |
Profit Before Tax | 24.23 | 27.39 | 3.04 | -11.5% | 697.0% |
Tax | 2.94 | 1.30 | -1.66 | 126.2% | -277.1% |
Profit After Tax | 72.15 | 65.39 | 48.25 | 10.3% | 49.5% |
Earnings Per Share | 2.80 | 2.50 | 1.90 | 12.0% | 47.4% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Alembic Ltd is primarily engaged in the pharmaceutical industry, focusing on the development, manufacture, and marketing of pharmaceutical products. As a prominent player in the industry, Alembic is known for its diverse range of products including generic formulations, active pharmaceutical ingredients (APIs), and specialty pharmaceuticals. The company operates across multiple markets, with a strong presence in both domestic and international arenas. While there is no specific information provided about recent developments in this data, Alembic Ltd typically engages in activities such as research and development, strategic partnerships, and expansions into new markets to enhance its portfolio and market reach.
Revenue
In the fourth quarter of the fiscal year 2025 (Q4FY25), Alembic Ltd reported a total income of ₹51.08 crores. This represents an 18.0% decrease from the previous quarter (Q3FY25) where the total income was ₹62.29 crores. However, when compared to the same quarter in the previous year (Q4FY24), the total income saw a significant increase of 30.4%, up from ₹39.16 crores. These figures indicate fluctuations in the company's revenue performance on a quarterly basis, while maintaining an upward trajectory year-over-year.
Profitability
Alembic Ltd's profitability metrics reveal notable changes. The profit before tax for Q4FY25 was ₹24.23 crores, experiencing an 11.5% decline from the preceding quarter's figure of ₹27.39 crores. However, compared to Q4FY24, where the profit before tax was ₹3.04 crores, there was a dramatic increase of 697.0%. The profit after tax for the current quarter stood at ₹72.15 crores, marking a 10.3% rise from the previous quarter and a substantial 49.5% increase from the same quarter last year. The earnings per share (EPS) also rose to ₹2.80 from ₹2.50 in Q3FY25 and ₹1.90 in Q4FY24, showcasing a 12.0% QoQ growth and a 47.4% YoY growth, respectively.
Operating Metrics
The total expenses for Alembic Ltd in Q4FY25 amounted to ₹26.86 crores, which represents a decrease of 23.0% from the ₹34.90 crores recorded in Q3FY25. Year-over-year, the total expenses increased by 5.3%, up from ₹25.51 crores in Q4FY24. The tax expense for the quarter was ₹2.94 crores, which is an increase from both the previous quarter’s ₹1.30 crores and a reversal from a negative tax figure of -₹1.66 crores in Q4FY24. This reflects a significant change in tax liabilities on a QoQ and YoY basis, with a 126.2% increase QoQ and a -277.1% change YoY. These operating metrics highlight the company's cost management strategies and tax implications over the analyzed periods.